Logo image of VRTS

VIRTUS INVESTMENT PARTNERS (VRTS) Stock Fundamental Analysis

NYSE:VRTS - New York Stock Exchange, Inc. - US92828Q1094 - Common Stock - Currency: USD

199.1  -1.61 (-0.8%)

After market: 199.1 0 (0%)

Fundamental Rating

5

Taking everything into account, VRTS scores 5 out of 10 in our fundamental rating. VRTS was compared to 233 industry peers in the Capital Markets industry. Both the profitability and the financial health of VRTS get a neutral evaluation. Nothing too spectacular is happening here. VRTS is not valued too expensively and it also shows a decent growth rate. Finally VRTS also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

VRTS had positive earnings in the past year.
In the past year VRTS had a positive cash flow from operations.
Each year in the past 5 years VRTS has been profitable.
Of the past 5 years VRTS 4 years had a positive operating cash flow.
VRTS Yearly Net Income VS EBIT VS OCF VS FCFVRTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

The Return On Assets of VRTS (3.27%) is comparable to the rest of the industry.
VRTS's Return On Equity of 13.49% is fine compared to the rest of the industry. VRTS outperforms 73.39% of its industry peers.
VRTS's Return On Invested Capital of 3.88% is in line compared to the rest of the industry. VRTS outperforms 48.93% of its industry peers.
VRTS had an Average Return On Invested Capital over the past 3 years of 3.76%. This is below the industry average of 7.84%.
The 3 year average ROIC (3.76%) for VRTS is below the current ROIC(3.88%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.27%
ROE 13.49%
ROIC 3.88%
ROA(3y)3.19%
ROA(5y)3.43%
ROE(3y)14.36%
ROE(5y)15.89%
ROIC(3y)3.76%
ROIC(5y)4.34%
VRTS Yearly ROA, ROE, ROICVRTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

VRTS has a Profit Margin (13.35%) which is in line with its industry peers.
In the last couple of years the Profit Margin of VRTS has declined.
VRTS has a Operating Margin (20.14%) which is in line with its industry peers.
In the last couple of years the Operating Margin of VRTS has declined.
Industry RankSector Rank
OM 20.14%
PM (TTM) 13.35%
GM N/A
OM growth 3Y-17.09%
OM growth 5Y-2.7%
PM growth 3Y-14.2%
PM growth 5Y-2.84%
GM growth 3YN/A
GM growth 5YN/A
VRTS Yearly Profit, Operating, Gross MarginsVRTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The number of shares outstanding for VRTS has been reduced compared to 1 year ago.
The number of shares outstanding for VRTS has been increased compared to 5 years ago.
Compared to 1 year ago, VRTS has a worse debt to assets ratio.
VRTS Yearly Shares OutstandingVRTS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
VRTS Yearly Total Debt VS Total AssetsVRTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

VRTS has an Altman-Z score of 0.87. This is a bad value and indicates that VRTS is not financially healthy and even has some risk of bankruptcy.
VRTS has a Altman-Z score (0.87) which is comparable to the rest of the industry.
VRTS has a debt to FCF ratio of 87.76. This is a negative value and a sign of low solvency as VRTS would need 87.76 years to pay back of all of its debts.
VRTS has a Debt to FCF ratio (87.76) which is comparable to the rest of the industry.
A Debt/Equity ratio of 2.54 is on the high side and indicates that VRTS has dependencies on debt financing.
VRTS has a worse Debt to Equity ratio (2.54) than 81.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF 87.76
Altman-Z 0.87
ROIC/WACCN/A
WACCN/A
VRTS Yearly LT Debt VS Equity VS FCFVRTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.05 indicates that VRTS has no problem at all paying its short term obligations.
VRTS has a Current ratio of 2.05. This is in the better half of the industry: VRTS outperforms 69.10% of its industry peers.
A Quick Ratio of 2.05 indicates that VRTS has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.05, VRTS is doing good in the industry, outperforming 69.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 2.05
VRTS Yearly Current Assets VS Current LiabilitesVRTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

VRTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.20%, which is quite good.
The Earnings Per Share has been growing by 12.37% on average over the past years. This is quite good.
VRTS shows a small growth in Revenue. In the last year, the Revenue has grown by 3.84%.
Measured over the past years, VRTS shows a quite strong growth in Revenue. The Revenue has been growing by 10.00% on average per year.
EPS 1Y (TTM)15.2%
EPS 3Y-9.8%
EPS 5Y12.37%
EPS Q2Q%5.91%
Revenue 1Y (TTM)3.84%
Revenue growth 3Y-2.52%
Revenue growth 5Y10%
Sales Q2Q%-1.31%

3.2 Future

The Earnings Per Share is expected to grow by 2.14% on average over the next years.
Based on estimates for the next years, VRTS will show a decrease in Revenue. The Revenue will decrease by -2.45% on average per year.
EPS Next Y-4%
EPS Next 2Y-0.63%
EPS Next 3Y2.14%
EPS Next 5YN/A
Revenue Next Year-7.27%
Revenue Next 2Y-4%
Revenue Next 3Y-2.45%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
VRTS Yearly Revenue VS EstimatesVRTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
VRTS Yearly EPS VS EstimatesVRTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.46, which indicates a rather cheap valuation of VRTS.
VRTS's Price/Earnings ratio is rather cheap when compared to the industry. VRTS is cheaper than 87.12% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.45. VRTS is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 7.65, which indicates a rather cheap valuation of VRTS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VRTS indicates a rather cheap valuation: VRTS is cheaper than 89.27% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.90. VRTS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.46
Fwd PE 7.65
VRTS Price Earnings VS Forward Price EarningsVRTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

81.55% of the companies in the same industry are more expensive than VRTS, based on the Enterprise Value to EBITDA ratio.
VRTS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 53.21
EV/EBITDA 14.1
VRTS Per share dataVRTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.6
EPS Next 2Y-0.63%
EPS Next 3Y2.14%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.52%, VRTS is a good candidate for dividend investing.
VRTS's Dividend Yield is comparable with the industry average which is at 8.00.
Compared to an average S&P500 Dividend Yield of 2.42, VRTS pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.52%

5.2 History

On average, the dividend of VRTS grows each year by 17.66%, which is quite nice.
VRTS has paid a dividend for at least 10 years, which is a reliable track record.
VRTS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)17.66%
Div Incr Years7
Div Non Decr Years10
VRTS Yearly Dividends per shareVRTS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

VRTS pays out 50.06% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of VRTS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP50.06%
EPS Next 2Y-0.63%
EPS Next 3Y2.14%
VRTS Yearly Income VS Free CF VS DividendVRTS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M
VRTS Dividend Payout.VRTS Dividend Payout, showing the Payout Ratio.VRTS Dividend Payout.PayoutRetained Earnings

VIRTUS INVESTMENT PARTNERS

NYSE:VRTS (7/3/2025, 8:16:30 PM)

After market: 199.1 0 (0%)

199.1

-1.61 (-0.8%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)04-25 2025-04-25/bmo
Earnings (Next)07-25 2025-07-25/bmo
Inst Owners83.57%
Inst Owner Change1.04%
Ins Owners6.15%
Ins Owner Change3.05%
Market Cap1.38B
Analysts46.67
Price Target171.87 (-13.68%)
Short Float %1.67%
Short Ratio1.19
Dividend
Industry RankSector Rank
Dividend Yield 4.52%
Yearly Dividend8.27
Dividend Growth(5Y)17.66%
DP50.06%
Div Incr Years7
Div Non Decr Years10
Ex-Date07-31 2025-07-31 (2.25)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.4%
Min EPS beat(2)-1%
Max EPS beat(2)3.8%
EPS beat(4)1
Avg EPS beat(4)-0.12%
Min EPS beat(4)-3.1%
Max EPS beat(4)3.8%
EPS beat(8)2
Avg EPS beat(8)-1.59%
EPS beat(12)4
Avg EPS beat(12)-1.43%
EPS beat(16)6
Avg EPS beat(16)-0.52%
Revenue beat(2)0
Avg Revenue beat(2)-2.88%
Min Revenue beat(2)-3.81%
Max Revenue beat(2)-1.95%
Revenue beat(4)0
Avg Revenue beat(4)-3.08%
Min Revenue beat(4)-3.81%
Max Revenue beat(4)-1.95%
Revenue beat(8)0
Avg Revenue beat(8)-3.65%
Revenue beat(12)3
Avg Revenue beat(12)0.58%
Revenue beat(16)7
Avg Revenue beat(16)3.89%
PT rev (1m)0%
PT rev (3m)-22.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.09%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.87%
Valuation
Industry RankSector Rank
PE 7.46
Fwd PE 7.65
P/S 1.52
P/FCF 53.21
P/OCF 42.34
P/B 1.54
P/tB 10.48
EV/EBITDA 14.1
EPS(TTM)26.68
EY13.4%
EPS(NY)26.03
Fwd EY13.07%
FCF(TTM)3.74
FCFY1.88%
OCF(TTM)4.7
OCFY2.36%
SpS130.66
BVpS129.34
TBVpS19.01
PEG (NY)N/A
PEG (5Y)0.6
Profitability
Industry RankSector Rank
ROA 3.27%
ROE 13.49%
ROCE 5.2%
ROIC 3.88%
ROICexc 4.03%
ROICexgc 5.22%
OM 20.14%
PM (TTM) 13.35%
GM N/A
FCFM 2.86%
ROA(3y)3.19%
ROA(5y)3.43%
ROE(3y)14.36%
ROE(5y)15.89%
ROIC(3y)3.76%
ROIC(5y)4.34%
ROICexc(3y)10.87%
ROICexc(5y)12.89%
ROICexgc(3y)110.04%
ROICexgc(5y)160.56%
ROCE(3y)5.04%
ROCE(5y)5.81%
ROICexcg growth 3Y-77.85%
ROICexcg growth 5Y3.06%
ROICexc growth 3Y-48.2%
ROICexc growth 5Y2.75%
OM growth 3Y-17.09%
OM growth 5Y-2.7%
PM growth 3Y-14.2%
PM growth 5Y-2.84%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF 87.76
Debt/EBITDA 9.12
Cap/Depr 9.92%
Cap/Sales 0.74%
Interest Coverage 250
Cash Conversion 13.06%
Profit Quality 21.45%
Current Ratio 2.05
Quick Ratio 2.05
Altman-Z 0.87
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)10.41%
Cap/Depr(5y)9.08%
Cap/Sales(3y)0.8%
Cap/Sales(5y)0.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.2%
EPS 3Y-9.8%
EPS 5Y12.37%
EPS Q2Q%5.91%
EPS Next Y-4%
EPS Next 2Y-0.63%
EPS Next 3Y2.14%
EPS Next 5YN/A
Revenue 1Y (TTM)3.84%
Revenue growth 3Y-2.52%
Revenue growth 5Y10%
Sales Q2Q%-1.31%
Revenue Next Year-7.27%
Revenue Next 2Y-4%
Revenue Next 3Y-2.45%
Revenue Next 5YN/A
EBIT growth 1Y20.18%
EBIT growth 3Y-19.18%
EBIT growth 5Y7.03%
EBIT Next Year-4.96%
EBIT Next 3Y-0.99%
EBIT Next 5YN/A
FCF growth 1Y-84.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.05%
OCF growth 3Y-86.19%
OCF growth 5YN/A